V. D. Dodge, E. M. Cox – Dodge & Cox Stock Fund Portfolio Activity & Recent Trades (Jun 30, 2025)
As of Jun 30, 2025, the Dodge & Cox Stock Fund portfolio activity showed several notable changes in holdings, according to the latest SEC 13F filing reported on Aug 13, 2025. The activity included new positions, additions to existing holdings, reductions, and complete exits, providing a clear view of how the portfolio evolved during the quarter.
During Q2 2025, the filing reported:
New Buys – Grupo Cibest, Archer-Daniels-Midland Company, Amrize, BioNTech SE, Laureate Education, Inc., and 4 more
Increases – Apple Inc., ACM Research, Inc., Afya, Amgen Inc., Amazon.com, Inc., and 55 more
Reductions – Adobe Inc., Analog Devices, Inc., Aegon Ltd. New York Registry Sh, American Electric Power Company, Alnylam Pharmaceuticals, Inc., and 103 more
These updates highlight how the portfolio adjusted across different sectors and market conditions, offering insights into allocation shifts and investment trends.
| Date | Symbol | Type | Change Qty |
|---|---|---|---|
Q2 2025 | 40090E106 Grupo Cibest | Buy - Position Entry | +12,046 |
Q2 2025 | AAPL Apple Inc. | Buy | +3,100 |
Q2 2025 | ACMR ACM Research, Inc. | Buy | +18,000 |
Q2 2025 | ADBE Adobe Inc. | Sell | -243 |
Q2 2025 | ADI Analog Devices, Inc. | Sell | -280 |
Q2 2025 | ADM Archer-Daniels-Midland Company | Buy - Position Entry | +6,549,624 |
Q2 2025 | AEG Aegon Ltd. New York Registry Sh | Sell | -28,804,015 |
Q2 2025 | AEP American Electric Power Company | Sell | -1,239,147 |
Q2 2025 | AFYA Afya | Buy | +4,000 |
Q2 2025 | ALNY Alnylam Pharmaceuticals, Inc. | Sell | -154,666 |
Q2 2025 | AMGN Amgen Inc. | Buy | +150 |
Q2 2025 | AMRZ Amrize | Buy - Position Entry | +12,470,706 |
Q2 2025 | AMZN Amazon.com, Inc. | Buy | +59,518 |
Q2 2025 | APD Air Products and Chemicals, Inc | Buy | +61,678 |
Q2 2025 | ASR Grupo Aeroportuario del Sureste | Sell | -100 |
Q2 2025 | AVGO Broadcom Inc. | Buy | +510 |
Q2 2025 | AVTR Avantor, Inc. | Buy | +17,170,761 |
Q2 2025 | AXP American Express Company | Sell | -15,758 |
Q2 2025 | AZN Astrazeneca PLC | Buy | +1,348 |
Q2 2025 | BABA Alibaba Group Holding Limited | Sell | -355,300 |
Q2 2025 | BAC Bank of America Corporation | Sell | -3,144,420 |
Q2 2025 | BAP Credicorp | Sell | -162,400 |
Q2 2025 | BAX Baxter International Inc. | Buy | +662,695 |
Q2 2025 | BDX Becton, Dickinson and Company | Sell - Position Exit | -980 |
Q2 2025 | BIDU Baidu, Inc. | Sell | -13,100 |
Q2 2025 | BK The Bank of New York Mellon Cor | Sell | -4,357,266 |
Q2 2025 | BKNG Booking Holdings Inc. Common St | Sell | -45,535 |
Q2 2025 | BKR Baker Hughes Company | Sell | -72,282 |
Q2 2025 | BMRN BioMarin Pharmaceutical Inc. | Buy | +153,070 |
Q2 2025 | BMY Bristol-Myers Squibb Company | Sell | -4,593,803 |